secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sunshine Biopharma Inc. (SBFM)
CIK:        0001402328
Form:       8-K
Filed at:   2026-08-28T20:05:23+00:00
Accession:  0001683168-26-006777
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Sunshine Biopharma director Dr. Andrew Keller will not seek reelection
----------------------------------------------------------------------

- Dr. Andrew Keller notified company on Aug 25, 2026 he will not seek reelection.
- His term expires at the next annual shareholder meeting; no replacement named.
- Board composition will change after his departure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1402328/000168316826006777/0001683168-26-006777-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1402328/000168316826006777/sunshine_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-26-006777

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer